Evidence map›Paper›PMID 33437180›Full record

ArticleCentral-European journal of immunology2020

Inflammation-associated gene polymorphisms and clinical variables in the incidence and progression of retinopathy of prematurity.

Dawid Szpecht, Anna Chmielarz-CzarnociŃska, Janusz Gadzinowski, Agnieszka Seremak-Mrozikiewicz, GraŻyna KurzawiŃska, Marta Szymankiewicz, Krzysztof Drews, Anna Gotz-WiĘckowska

Open access · goldAbstract read
In one paragraph

Article in Central-European journal of immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Dawid SzpechtChair and Department of Neonatology, Poznan University of Medical Sciences, Poznan, Poland.
Anna Chmielarz-CzarnociŃskaChair and Department of Ophthalmology, Poznan University of Medical Sciences, Poznan, Poland.
Janusz GadzinowskiChair and Department of Neonatology, Poznan University of Medical Sciences, Poznan, Poland.
Agnieszka Seremak-MrozikiewiczDepartment of Perinatology and Women's Diseases, Poznan University of Medical Sciences, Poznan, Poland.
GraŻyna KurzawiŃskaDepartment of Perinatology and Women's Diseases, Poznan University of Medical Sciences, Poznan, Poland.
Marta SzymankiewiczChair and Department of Neonatology, Poznan University of Medical Sciences, Poznan, Poland.
Krzysztof DrewsDepartment of Perinatology and Women's Diseases, Poznan University of Medical Sciences, Poznan, Poland.
Anna Gotz-WiĘckowskaChair and Department of Ophthalmology, Poznan University of Medical Sciences, Poznan, Poland.
Poznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionA growing body of evidence shows that genetics plays a vital role in the development and progression of retinopathy of prematurity (ROP). Perinatal inflammation is also considered an important risk factor of ROP. Therefore, understanding the interplay of genetics and susceptibility to inflammation might shed light on the pathogenesis of ROP and make its screening and treatment more effective in preventing visual impairment in premature infants. MATERIAL AND

methodsThis study investigated the correlation of inflammation-associated gene polymorphisms: IL-1

resultsOur results demonstrate that IL-1RN rs2234663 1/1 genotype prevails in infants with ROP that regresses without intervention, when compared to those requiring laser photocoagulation/anti-VEGF injection (p = 0.031). Genotype 2/2 of IL-1RN occurs more frequently in children with severe ROP (28.6%) than in the group in which ROP regressed spontaneously (4.0%). The analysis revealed also differences between the genotypes of IL-1RN in ROP patients with intrauterine infection and in patients who had ROP without intrauterine infection; however, this was not statistically significant. Other studied polymorphisms were not associated with ROP development or its progression.

conclusionsThese results suggest that different genotypes of IL-1RN might have an impact on the course of ROP. Genotype 2/2 of IL-1RN gene may predispose to ROP progression.

Indexed as

inflammationlaser photocoagulationpolymorphismranibizumab injectionretinopathy of prematurity (ROP)

Identifiers

PMID33437180
PMCPMC7790002
OpenAlexW3027857502

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.